共 50 条
- [1] Pharmaceutical regulation in Europe and its impact on corporate R&D[J]. HEALTH ECONOMICS REVIEW, 2014, 4Eger, StephanMahlich, Joerg C.
- [2] Pharmaceutical regulation in Europe and its impact on corporate R&D[J]. Health Economics Review, 4 (1)Stephan EgerJörg C Mahlich
- [3] The impact of mergers on pharmaceutical R&D[J]. Nature Reviews Drug Discovery, 2011, 10 : 559 - 560John L. LaMattina
- [4] The impact of mergers on pharmaceutical R&D[J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (08) : 559 - 560LaMattina, John L.
- [5] The Dynamics of Pharmaceutical Regulation and R&D Investments[J]. JOURNAL OF PUBLIC ECONOMIC THEORY, 2017, 19 (01) : 121 - 141Levaggi, RosellaMoretto, MichelePertile, Paolo
- [6] Trajectories in pharmaceutical R&D, markets, and regulation[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2006, 231Daemmrich, Arthur
- [7] Corporate Governance and Its Impact on R&D Investment in Emerging Markets[J]. EMERGING MARKETS FINANCE AND TRADE, 2017, 53 (10) : 2159 - 2178Rapp, Marc SteffenUdoieva, Iuliia A.
- [8] The Internationalization of Corporate R&D and the Automotive Industry R&D of East-Central Europe[J]. ECONOMIC GEOGRAPHY, 2012, 88 (03) : 279 - 310Pavlinek, Petr
- [9] Corporate governance and the impact to the R&D lab[J]. JOURNAL OF STRATEGY AND MANAGEMENT, 2020, 13 (01) : 91 - 110Markus, ArjanSwift, Tim
- [10] Pharmaceutical R&D Spending and Threats of Price Regulation[J]. JOURNAL OF FINANCIAL AND QUANTITATIVE ANALYSIS, 2010, 45 (01) : 239 - 264Golec, JosephHegde, ShantaramVernon, John A.